OBINUTUZUMAB for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,193 adverse event reports in the FDA FAERS database where OBINUTUZUMAB was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for OBINUTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,584 | 11.2% | 139 | 239 |
| Neutropenia | 1,276 | 9.0% | 112 | 331 |
| Febrile neutropenia | 955 | 6.7% | 91 | 473 |
| Covid-19 | 942 | 6.6% | 263 | 505 |
| Pyrexia | 920 | 6.5% | 122 | 525 |
| Thrombocytopenia | 889 | 6.3% | 77 | 164 |
| Disease progression | 831 | 5.9% | 184 | 75 |
| Infusion related reaction | 789 | 5.6% | 58 | 252 |
| Pneumonia | 662 | 4.7% | 170 | 445 |
| Anaemia | 640 | 4.5% | 53 | 111 |
| Atrial fibrillation | 548 | 3.9% | 36 | 141 |
| Infection | 517 | 3.6% | 69 | 94 |
| Chills | 483 | 3.4% | 15 | 158 |
| Dyspnoea | 478 | 3.4% | 59 | 187 |
| Nausea | 470 | 3.3% | 37 | 166 |
Other Indications for OBINUTUZUMAB
Chronic lymphocytic leukaemia (4,557)
Follicular lymphoma (2,527)
Product used for unknown indication (1,743)
B-cell lymphoma (1,200)
Mantle cell lymphoma (441)
Non-hodgkin's lymphoma (387)
Lymphoma (238)
Marginal zone lymphoma (188)
Chemotherapy (135)
Central nervous system lymphoma (133)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)